FDA Clearance Tracker · K171537
CAPI 3 Hb A1c
Last checked: Nov 20, 2026Latest source record: Sep 12, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Sep 12, 2017
Substantially Equivalent
Time to decision
110 days
Received May 25, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K171537
- Device name
- CAPI 3 Hb A1c
- Applicant
- Sebia
- Applicant location
- Norcross, GA
- Received
- May 25, 2017
- Decided
- Sep 12, 2017
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Hemoglobin A1c Test System (PDJ)
- Device class
- Class II
- Regulation
- 21 CFR 862.1373
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code PDJ. The earliest in FDA's data is DEN130002, decided May 23, 2013.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K171537
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Sebia
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K232027 · Decided Apr 4, 2024 · 272 days after receipt
Device type: Abnormal Hemoglobin Quantitation (GKA) · Laboratory Medicine & Pathology
K231601 · Decided Feb 23, 2024 · 267 days after receipt
Device type: Kappa, Antigen, Antiserum, Control (DFH) · Laboratory Medicine & Pathology
K210623 · Decided Nov 18, 2022 · 626 days after receipt
Device type: Kappa, Antigen, Antiserum, Control (DFH) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.